NIPENT
Formula & Concentration
NIPENT- pentostatin injection, powder, lyophilized, for solution
Manufacturer
Pfizer Inc.
Indications
NIPENT is indicated as single-agent treatment for both untreated and alpha-interferon-refractory hairy cell leukemia patients with active disease as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms.
Shelf Life and Storage
Store NIPENT vials under refrigerated storage conditions 2° to 8° C (36° to 46°F).




